Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOBUTAMINE vs DOCONEXENT\ICOSAPENT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOBUTAMINE vs DOCONEXENT\ICOSAPENT: Safety Overview

Metric DOBUTAMINE DOCONEXENT\ICOSAPENT
Total FAERS Reports 1,632 165
Deaths Reported 611 16
Death Rate 37.4% 9.7%
Hospitalizations 809 149
Average Patient Age 65.0 yrs 52.5 yrs
% Female Patients 27.1% 60.5%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued N/A